HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshio Hosoi Selected Research

Ku Autoantigen

7/2005Prognostic significance of Ku70 protein expression in patients with advanced colorectal cancer.
9/2002The expression pattern of Ku correlates with tumor radiosensitivity and disease free survival in patients with rectal carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshio Hosoi Research Topics

Disease

10Neoplasms (Cancer)
10/2018 - 09/2002
3Ataxia Telangiectasia (Louis Bar Syndrome)
01/2021 - 10/2004
3Starvation
01/2020 - 12/2015
2Leukemia
01/2022 - 10/2003
2Hypoxia (Hypoxemia)
10/2018 - 01/2018
2Liver Neoplasms (Liver Cancer)
01/2018 - 12/2015
2Colorectal Neoplasms (Colorectal Cancer)
07/2005 - 08/2004
1Glioblastoma (Glioblastoma Multiforme)
01/2020
1Myocardial Infarction
10/2016
1Inflammation (Inflammations)
10/2016
1Wounds and Injuries (Trauma)
01/2016
1Carcinogenesis
10/2015
1Stomach Neoplasms (Stomach Cancer)
10/2015
1Bone Marrow Failure Disorders
07/2013
1Head and Neck Neoplasms (Head and Neck Cancer)
03/2009
1Taste Disorders (Taste Disorder)
03/2009
1Neuroblastoma
01/2009
1Schizophrenia (Dementia Praecox)
01/2009
1Rectal Neoplasms (Rectal Cancer)
07/2008
1Cerebral Infarction
11/2007
1Prostatic Neoplasms (Prostate Cancer)
09/2006
1Esophageal Neoplasms (Esophageal Cancer)
09/2006
1Breast Neoplasms (Breast Cancer)
01/2006
1Chromosome Aberrations (Chromosome Abnormalities)
01/2006
1Chromosomal Instability (Chromosome Stability)
01/2006
1Hepatocellular Carcinoma (Hepatoma)
12/2005
1Adenocarcinoma
07/2005
1Glioma (Gliomas)
10/2004
1Hyperthermia
10/2004
1T-Cell Leukemia (Leukemia, T Cell)
10/2003
1Carcinoma (Carcinomatosis)
09/2002
1Nijmegen Breakage Syndrome
08/2002

Drug/Important Bio-Agent (IBA)

9DNA (Deoxyribonucleic Acid)IBA
01/2020 - 08/2004
5Proteins (Proteins, Gene)FDA Link
01/2022 - 08/2004
5lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
01/2020 - 08/2004
5DNA-Activated Protein KinaseIBA
10/2018 - 08/2004
4Small Interfering RNA (siRNA)IBA
01/2020 - 12/2015
2Mechanistic Target of Rapamycin Complex 1IBA
01/2018 - 12/2015
2Ku AutoantigenIBA
07/2005 - 09/2002
13-methylquercetinIBA
01/2021
1Oxygen (Dioxygen)IBA
10/2018
1Caveolin 1IBA
10/2018
1GlycogenIBA
01/2018
1Cell Adhesion MoleculesIBA
10/2016
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
10/2016
1AMP-Activated Protein KinasesIBA
12/2015
1TOR Serine-Threonine KinasesIBA
12/2015
1Sirolimus (Rapamycin)FDA Link
12/2015
11,5- bis(3,5- bis(methoxymethoxy)phenyl)penta- 1,4- dien- 3- oneIBA
10/2015
1CateninsIBA
10/2015
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2015
1Prostaglandin-E SynthasesIBA
10/2015
1CurcuminIBA
10/2015
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
10/2015
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2014
1Rifabutin (Ansamycin)FDA Link
11/2013
1tanespimycin (17AAG)IBA
11/2013
1Vanadates (Orthovanadate)IBA
07/2013
1DysbindinIBA
01/2009
1Protein Isoforms (Isoforms)IBA
01/2009
1EdaravoneIBA
11/2007
1Pharmaceutical PreparationsIBA
11/2007
1Free RadicalsIBA
11/2007
1Phosphotransferases (Kinase)IBA
10/2004
1Biological ProductsIBA
10/2004
1Radiation-Sensitizing AgentsIBA
10/2004
1Messenger RNA (mRNA)IBA
08/2004
1WortmanninIBA
10/2003
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
08/2002

Therapy/Procedure

4Radiotherapy
03/2009 - 09/2002
2Therapeutics
10/2015 - 10/2004
1Nuclear Power Plants
01/2016
1Drug Therapy (Chemotherapy)
10/2015
1Oral Administration
10/2015